In the case of melanoma, COX-2 increases vascular endothelial growth factor (VEGF) expression in the tumor milieu through the phosphoinositide 3-kinase (PI3K)/protein kinase C (PKC) signaling pathway and thus it promotes tumor-induced angiogenesis. Here, PTGS2 is linked to melanoma.